Company Search:
Advanced Search
Sponsored Links
Tus-Guhan Group Corp Ltd Company Snapshot
Tus-Guhan Group Corp Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tus-Guhan Group Corp Ltd with three other companies in this sector in China: Hainan Poly Pharm Co Ltd (2017 sales of 324.83 million Chinese Renmimbi [US$50.91 million] of which 43% was Antiallergic drugs), Real Nutriceutical Group Ltd (357.66 million Chinese Renmimbi [US$56.06 million] of which 82% was Health and nutritional supplements), and Shenyang Xingqi Pharmaceutical Co Ltd (360.01 million Chinese Renmimbi [US$56.43 million] of which 100% was Pharmaceutical manufacturing industry).

Sales Analysis. Tus-Guhan Group Corp Ltd reported sales of 343.54 million Chinese Renmimbi (US$53.85 million) for the year ending December of 2017. This represents an increase of 8.2% versus 2016, when the company's sales were 317.41 million Chinese Renmimbi. This was the third consecutive year of growth at Tus-Guhan Group Corp Ltd. The sales level in 2017 was fairly close to the level five years ago: in 2012, Tus-Guhan Group Corp Ltd had sales of 362.83 million Chinese Renmimbi. Sales of Others saw an increase that was more than double the company's growth rate: sales were up 994.8% in 2017, from 54,843.31 Chinese Renmimbi to 600,441.68 Chinese Renmimbi. Tus-Guhan Group Corp Ltd also saw significant increases in sales in Pharmaceutical Wholesale and Retail (up 219.3% to 50.63 million Chinese Renmimbi) . Not all segments of Tus-Guhan Group Corp Ltd experienced an increase in sales in 2017: sales of Western Medicine Manufacturing fell 15.4% to 16.80 million Chinese Renmimbi. Tus-Guhan Group Corp Ltd also experienced decreases in sales in Tcm and Tonics Manufacturing (down 2.2% to 275.51 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tus-Guhan Group Corp Ltd
  Stock Performance Chart for Tus-Guhan Group Corp Ltd
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 13.82
(Figures in Chinese Renmimbi)
1 Week 1.5%   13 Weeks n/a  
4 Weeks 24.3%   52 Weeks -15.3%  
Tus-Guhan Group Corp Ltd Key Data:
  Ticker: 000590 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 343,539,199
(Year Ending Jan 2018).
Employees: 1,466
  Currency: Chinese Renmimbi Market Cap: 3,309,492,910
  Fiscal Yr Ends: December Shares Outstanding: 239,471,267
  Share Type: A Gu Closely Held Shares: 124,535,627
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.